AKT1 and cancer: Studies have shown that CU or PTX can promote cancer cell apoptosis by inhibiting the phosphorylation of Akt in the PI3K/Akt pathway and then upregulating Bax and downregulating the expression of Bcl-2 protein (Hwang et al., 2016).